Leland Gershell
2013 - Tonix Pharmaceuticals Holding
In 2013, Leland Gershell earned a total compensation of $725.2K as Chief Financial Officer at Tonix Pharmaceuticals Holding, which was about the same as previous year.
Compensation breakdown
| Bonus | $128,750 |
|---|---|
| Option Awards | $411,075 |
| Salary | $185,415 |
| Total | $725,240 |
Gershell received $411.1K in option awards, accounting for 57% of the total pay in 2013.
Gershell also received $128.8K in bonus and $185.4K in salary.
Rankings
In 2013, Leland Gershell's compensation ranked 7,971st out of 12,286 executives tracked by ExecPay. In other words, Gershell earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,971 out of 12,286 | 35th |
Division Manufacturing | 2,886 out of 4,612 | 37th |
Major group Chemicals And Allied Products | 904 out of 1,466 | 38th |
Industry group Drugs | 687 out of 1,160 | 41st |
Industry Pharmaceutical Preparations | 542 out of 890 | 39th |
Source: SEC filing on March 25, 2016.
Gershell's colleagues
We found two more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2013.